Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Imaging features that distinguish pure ductal carcinoma in situ (DCIS) from DCIS with microinvasion.

Wang H, Lin J, Lai J, Tan C, Yang Y, Gu R, Jiang X, Liu F, Hu Y, Su F.

Mol Clin Oncol. 2019 Sep;11(3):313-319. doi: 10.3892/mco.2019.1891. Epub 2019 Jul 3.

2.

Correlation between sonographic findings and clinicopathologic and biologic features of pure ductal carcinoma in situ in 691 patients.

Scoggins ME, Fox PS, Kuerer HM, Rauch GM, Benveniste AP, Park YM, Lari SA, Krishnamurthy S, Yang WT.

AJR Am J Roentgenol. 2015 Apr;204(4):878-88. doi: 10.2214/AJR.13.12221.

PMID:
25794082
3.

Ductal carcinoma in situ with microinvasion: prognostic implications, long-term outcomes, and role of axillary evaluation.

Parikh RR, Haffty BG, Lannin D, Moran MS.

Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):7-13. doi: 10.1016/j.ijrobp.2010.08.027. Epub 2010 Oct 13.

PMID:
20950955
4.

DCIS with Microinvasion: Is It In Situ or Invasive Disease?

Champion CD, Ren Y, Thomas SM, Fayanju OM, Rosenberger LH, Greenup RA, Menendez CS, Hwang ES, Plichta JK.

Ann Surg Oncol. 2019 Oct;26(10):3124-3132. doi: 10.1245/s10434-019-07556-9. Epub 2019 Jul 24.

PMID:
31342393
5.

Microinvasive ductal carcinoma in situ: clinical presentation, imaging features, pathologic findings, and outcome.

Vieira CC, Mercado CL, Cangiarella JF, Moy L, Toth HK, Guth AA.

Eur J Radiol. 2010 Jan;73(1):102-7. doi: 10.1016/j.ejrad.2008.09.037. Epub 2008 Nov 21.

PMID:
19026501
6.

Sonographic Features of Ductal Carcinoma In Situ of the Breast With Microinvasion: Correlation With Clinicopathologic Findings and Biomarkers.

Yao JJ, Zhan WW, Chen M, Zhang XX, Zhu Y, Fei XC, Chen XS.

J Ultrasound Med. 2015 Oct;34(10):1761-8. doi: 10.7863/ultra.15.14.07059. Epub 2015 Aug 31.

PMID:
26324758
7.

The clinical features and management of women with ductal carcinoma in situ with microinvasion: A retrospective Cohort study.

Li Y, Zhang S, Wei X, Zhang J.

Int J Surg. 2015 Jul;19:91-4. doi: 10.1016/j.ijsu.2015.05.013. Epub 2015 May 23.

8.

Sentinel lymph node biopsy in patients affected by breast ductal carcinoma in situ with and without microinvasion: Retrospective observational study.

Bertozzi S, Cedolini C, Londero AP, Baita B, Giacomuzzi F, Capobianco D, Tortelli M, Uzzau A, Mariuzzi L, Risaliti A.

Medicine (Baltimore). 2019 Jan;98(1):e13831. doi: 10.1097/MD.0000000000013831.

9.

Screening-detected and symptomatic ductal carcinoma in situ: differences in the sonographic and pathologic features.

Shin HJ, Kim HH, Kim SM, Kwon GY, Gong G, Cho OK.

AJR Am J Roentgenol. 2008 Feb;190(2):516-25. doi: 10.2214/AJR.07.2206.

PMID:
18212241
10.

Do sentinel node micrometastases predict recurrence risk in ductal carcinoma in situ and ductal carcinoma in situ with microinvasion?

Murphy CD, Jones JL, Javid SH, Michaelson JS, Nolan ME, Lipsitz SR, Specht MC, Lesnikoski BA, Hughes KS, Gadd MA, Smith BL.

Am J Surg. 2008 Oct;196(4):566-8. doi: 10.1016/j.amjsurg.2008.06.011. Epub 2008 Aug 29.

PMID:
18760400
11.
12.

MR features to suggest microinvasive ductal carcinoma of the breast: can it be differentiated from pure DCIS?

Hahn SY, Han BK, Ko EY, Shin JH, Hwang JY, Nam M.

Acta Radiol. 2013 Sep;54(7):742-8. doi: 10.1177/0284185113484640. Epub 2013 Apr 30.

PMID:
23588154
13.

Role of axillary staging in women diagnosed with ductal carcinoma in situ with microinvasion.

Pimiento JM, Lee MC, Esposito NN, Kiluk JV, Khakpour N, Carter WB, Han G, Laronga C.

J Oncol Pract. 2011 Sep;7(5):309-13. doi: 10.1200/JOP.2010.000096. Epub 2011 Jul 27.

14.

Clinicopathologic, mammographic, and sonographic features in 1,187 patients with pure ductal carcinoma in situ of the breast by estrogen receptor status.

Rauch GM, Kuerer HM, Scoggins ME, Fox PS, Benveniste AP, Park YM, Lari SA, Hobbs BP, Adrada BE, Krishnamurthy S, Yang WT.

Breast Cancer Res Treat. 2013 Jun;139(3):639-47. doi: 10.1007/s10549-013-2598-7. Epub 2013 Jun 18.

15.

Factors predicting microinvasion in Ductal Carcinoma in situ.

Ozkan-Gurdal S, Cabioglu N, Ozcinar B, Muslumanoglu M, Ozmen V, Kecer M, Yavuz E, Igci A.

Asian Pac J Cancer Prev. 2014;15(1):55-60.

16.

Risk factors for lymph node metastasis and the impact of adjuvant chemotherapy on ductal carcinoma in situ with microinvasion: a population-based study.

Chen C, Huang S, Huang A, Jia Y, Wang J, Zhang Z, Mao M, Wang L, Zhou J.

Onco Targets Ther. 2018 Dec 13;11:9071-9080. doi: 10.2147/OTT.S186228. eCollection 2018.

17.

An update of sentinel lymph node mapping in patients with ductal carcinoma in situ.

Wilkie C, White L, Dupont E, Cantor A, Cox CE.

Am J Surg. 2005 Oct;190(4):563-6.

PMID:
16164920
18.

Screening-detected calcified and non-calcified ductal carcinoma in situ: differences in the imaging and histopathological features.

Mun HS, Shin HJ, Kim HH, Cha JH, Kim H.

Clin Radiol. 2013 Jan;68(1):e27-35. doi: 10.1016/j.crad.2012.09.003. Epub 2012 Nov 22.

PMID:
23177096
19.

A Nomogram to Predict Factors Associated with Lymph Node Metastasis in Ductal Carcinoma In Situ with Microinvasion.

Gooch JC, Schnabel F, Chun J, Pirraglia E, Troxel AB, Guth A, Shapiro R, Axelrod D, Roses D.

Ann Surg Oncol. 2019 Sep 16. doi: 10.1245/s10434-019-07750-9. [Epub ahead of print]

PMID:
31529311
20.

Is Sentinel Lymph Node Biopsy Required for a Core Biopsy Diagnosis of Ductal Carcinoma In Situ with Microinvasion?

Flanagan MR, Stempel M, Brogi E, Morrow M, Cody HS 3rd.

Ann Surg Oncol. 2019 Sep;26(9):2738-2746. doi: 10.1245/s10434-019-07475-9. Epub 2019 May 30.

PMID:
31147995

Supplemental Content

Support Center